<code id='FF7B1C6F1D'></code><style id='FF7B1C6F1D'></style>
    • <acronym id='FF7B1C6F1D'></acronym>
      <center id='FF7B1C6F1D'><center id='FF7B1C6F1D'><tfoot id='FF7B1C6F1D'></tfoot></center><abbr id='FF7B1C6F1D'><dir id='FF7B1C6F1D'><tfoot id='FF7B1C6F1D'></tfoot><noframes id='FF7B1C6F1D'>

    • <optgroup id='FF7B1C6F1D'><strike id='FF7B1C6F1D'><sup id='FF7B1C6F1D'></sup></strike><code id='FF7B1C6F1D'></code></optgroup>
        1. <b id='FF7B1C6F1D'><label id='FF7B1C6F1D'><select id='FF7B1C6F1D'><dt id='FF7B1C6F1D'><span id='FF7B1C6F1D'></span></dt></select></label></b><u id='FF7B1C6F1D'></u>
          <i id='FF7B1C6F1D'><strike id='FF7B1C6F1D'><tt id='FF7B1C6F1D'><pre id='FF7B1C6F1D'></pre></tt></strike></i>

          Home / comprehensive / explore

          explore


          explore

          author:leisure time    Page View:617
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In